Shenmai Injection enhances short-term outcomes in ischemic stroke patients after thrombolysis via AMPKα1

BackgroundShenmai Injection (SMI), a traditional Chinese medicine with nourishing properties, has been explored for its therapeutic effects in ischemic stroke (IS). This study aimed to evaluate the protective effects of SMI in patients with IS who received intravenous thrombolysis and to elucidate i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Wu, Zhonghao Li, Xiaoke Dong, Jinmin Liu, Le Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1552493/full
Tags: Add Tag
No Tags, Be the first to tag this record!